Fate Therapeutics's total assets for Q2 2025 were $371.63M, a decrease of -6.78% from the previous quarter. FATE total liabilities were $110.27M for the fiscal quarter, a <0.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.